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Brucellosis is a vital zoonotic disease caused by Brucella, which infects a wide range of animals and humans.
Accurate diagnosis and reliable vaccination can control brucellosis in domestic animals. This study examined novel
immunogenic proteins that can be used to detect Brucella abortus infection or as an effective subcellular vaccine. In
an immunoproteomic assay, 55 immunodominant proteins from B. abortus 544 were observed using two
dimensional electrophoresis (2DE) and immunoblot profiles with antisera from B. abortus-infected cattle at the early
(week 3), middle (week 7), and late (week 10) periods, after excluding protein spots reacting with antisera from
Yersinia enterocolitica O:9-infected and non-infected cattle. Twenty-three selected immunodominant proteins whose
spots were observed at all three infection periods were identified using MALDI-MS/MS. Most of these proteins identified
by immunoblot and mass spectrometry were determined by their subcellular localization and predicted function. We
suggest that the detection of prominent immunogenic proteins during the infection period can support the
development of advanced diagnostic methods with high specificity and accuracy; subsidiarily, these proteins can
provide supporting data to aid in developing novel vaccine candidates.Introduction
Brucella spp. are the etiological agents for brucellosis, a
debilitating and chronic disease infecting a variety of
domestic animals and humans. Brucellosis is characterized
by abortion and sterility in livestock as well as undulant
fever, arthritis and neurological disorders in humans [1].
Definitive diagnosis is commonly performed by isolation
and identification of the causative organism(s), but be-
cause the isolation is time-consuming and dangerous,
serological analysis is widely preferred [2]. Several specific
serological tests have been developed for the definitive
diagnosis of brucellosis, and these tests have been
upgraded repeatedly to obtain reliable data [3]. However, a
large number of tests still rely on presumptive evidence of* Correspondence: kimsuk@gnu.ac.kr
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use antibodies against common antigens of Brucella [4].
O-polysaccharide (OPS), a well-known immunodomi-
nant epitope in smooth lipopolysaccharide (SLPS) is a
commonly used antigen in serological tests for the diag-
nosis of brucellosis [5,6]. Consequently, the serological
diagnosis of brucellosis is complicated by cross-reactions
of the antibodies against other Gram-negative bacteria,
such as Y. enterocolitica O:9, which have conserved and
highly analogous OPS structures [7,8]. Therefore, it is cru-
cial to discover highly specific Brucella antigens that are
immunogenic in the host. Several studies have focused on
the use of antigenic proteins for alternative diagnostic
methods and to improve vaccine efficacy. Recent studies
have focused on the use of immunogenic proteins for
serodiagnosis of brucellosis [9].
Several immunogenic proteins of B. abortus have been
identified [10], but the antigens that are immunogenic at
different stages of the infection have not been defined.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cerning the different stages of infection is important for
the diagnosis and control of the disease. In this study,
we obtained antisera against B. abortus from experi-
mentally infected cattle at different stages of infection
and studied unique immunogenic proteins to validate the
immunogenic relationships and potential immunodomi-
nant markers at different stages of infection.
Materials and methods
Bacterial strains and culture conditions
The standard reference strains B. abortus 2308 and B.
abortus 544, which are known as virulent biovar 1 strain,
and Y. enterocoitica O:9 used in the present study were
obtained from the Laboratory of Bacteriology Division in
the Animal and Plant Quarantine Agency, Korea. The
bacteria were cultured at 37 °C with aeration until the
cells entered stationary phase. Subsequently, the number
of viable bacteria was evaluated by plating 10-fold serial
dilutions (made using PBS) on Brucella agar plates.
Preparation of antisera
Twenty-five apparently healthy Korean native heifers
(Hanwoo) aged 18–20 months were used in this study.
All animals were seronegative for brucellosis before im-
mune challenge, as assessed by the standard tube agglu-
tination test (STAT) and Rose Bengal test (RBT), which
are internationally accepted serological tests for bovine
brucellosis described by the OIE [5]. The cattle were
divided into 3 groups: B. abortus-infected (n = 10), Y.
enterocoitica O:9-infected (n = 10) and uninfected con-
trols (n = 5). Bacterial inoculation was performed as de-
scribed in previous methods [11]. Briefly, the first group
was inoculated with 4 × 107 CFU of B. abortus 2308/
head injecting a total of 100 μL (50 μL of inoculum per
eye) via the intraconjunctival route. The second group
was inoculated with 5 × 106 CFU of Y. enterocoitica O:9/
head 3 times by 1 day interval via subcutaneous injec-
tion. The 5 cattle in the uninfected control group were
inoculated with sterile PBS. After immune challenge,
antisera against B. abortus were collected at three stages
of infection; early (week 3), middle (week 7), and late
(week 10). These time points in three stages of infection
were determined based on low serological variations
among individuals and high titer values. Samples were
collected from all cattle in all groups. Using serological
tests, 3 samples of each B. abortus-infected antisera
(RBT-positive and STAT titers of > 1:400 at 3, 7, and
10 weeks post-challenge), Y. enterocoitica-infected anti-
sera (RBT-negative and STAT titers of 1:200 against
Brucella antigen at 3, 7 and 10 weeks post challenge),
and non-infected sera were selected and used for immune
analysis. The experimental procedures were approved by
the ethical committee as NVRQS-AEC-2008-12, and theinfected animals were euthanized according to the proto-
col of the Institution for Animal Care & Use Committee
in Korea.
Preparations of antigens
Antigens were prepared as a protein mixture of whole
cells including cell envelopes for proteomic analysis
using a modification of a previously described procedure
[10]. Briefly, B. abortus 544 cultures were centrifuged at
8000 × g for 20 min at 4 °C and washed 3 times with ice-
cold PBS (pH 7.6) by centrifugation. The bacterial pellet
was resuspended in 50 mM Tris–HCl (pH 7.6) con-
taining a complete protease inhibitor cocktail (PIC) and
then sonicated on ice using a Sonifier 750 (Branson
Ultrasonics, USA). The sonicated solution was centri-
fuged at 12 000 × g for 1 h at 4 °C, and the pellet was re-
suspended in lysis buffer (5 M urea, 2 M thiourea, 2%
CHAPS, 1% SB 3–10, 1% DTT, and containing PIC)
followed by incubation at 22 °C for 1 h with vigorous
agitation. After centrifugation at 100 000 × g for 30 min,
the supernatant was collected. The protein concentra-
tion was quantified using the Bradford assay [12].
Isoelectric focusing (IEF) and 2D SDS-PAGE
IEF and 2DE were conducted using a previously described
method [13] with modifications. Eighteen-centimeter IPG
strips (pH 3–10 and 4–7, GE Healthcare, USA) were rehy-
drated for 14 h at 22 °C with the lysed proteins and rehy-
dration buffer (7 M urea, 2 M thiourea, 2% CHAPS, 0.2%
DTT, 0.5% IPG buffer (pH 4–7), and 0.002% bromophenol
blue). IEF was performed on a Protean IEF gel (GE
Healthcare) at 20 °C for 14 h using the following condi-
tions: 500 V for 1 h, gradient phase of 1000 V for 1 h,
1000 V for 3 h, gradient phase of 10 000 V for 3 h,
10 000 V for 5 h, 50 V for 30 min and a final phase of 50 V
for 30 min. After IEF, each strip was equilibrated in 5 mL
of equilibration buffer I (6 M urea, 50 mM Tris–HCl
pH 8.8, 1% DTT, 30% glycerol, 2% SDS, and 0.002% bro-
mophenol blue) for 15 min at 22 °C and then in equilibra-
tion buffer II (6 M urea, 50 mM Tris–HCl pH 8.8, 2.5%
iodoacetamide, 30% glycerol, 2% SDS, and 0.002% bromo-
phenol blue) under the same conditions. The equilibrated
strips were loaded on the top of 12% SDS-polyacrylamide
gels and sealed with melted 1% agarose solution. The pro-
teins were two-dimensionally separated in resolving buffer
(25 mM Tris pH 8.8, 192 mM glycine, 0.1% SDS) using
Criterion electrophoresis equipment (Bio-Rad) equipped
with a cooling device (Lauda E100, Germany), kept at 25 °C
and supplied with regular power in two steps: 5 W/gel for
30 min and 20 W/gel until the protein dye reached the
bottom of the gel (approximately 5 h). The separated pro-
teins were transferred to PVDF membranes (Millipore,
USA) for immunoblotting analysis; simultaneously,
replicate gels containing the same protein samples were
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2DE were performed in independent experiments.
Immunoblotting with antisera
The proteins were completely transferred to membranes
using the TE70/77 PWR Semi-Dry Transfer Unit (GE
Healthcare) according to the manufacturer’s instructions.
The membranes were blocked for 1 h at room tempera-
ture using 5% rabbit serum in Tris-buffered saline con-
taining 0.1% Tween-20 (TBS-T) and then washed three
times for 20 min in TBS-T. The blots were incubated
overnight at 4 °C with a 1:500 dilution of the antisera
derived from the immune-challenged and control cattle.
The blots were then incubated for 1 h at room tempe-
rature with a 1:5000 dilution of goat anti-bovine IgG
HRP-conjugated antibody (Sigma, USA). After washing,
the immunolabeling was detected using ECL Western
blotting reagents (GE Healthcare). Finally, specific im-
munogenic proteins were visualized using a ChemiDoc
XRS Camera and the Quantity One 1D analysis software
(Bio-Rad).
Gel image analysis and in-gel trypsin digestion
The silver-stained 2D gels were scanned using an
ImageScanner™ (GE Healthcare) and cropped using
ImageQuant TL (GE Healthcare). Automatic gel-image
alignment and spot detection along with spot matching
were performed using Progenesis SameSpots v 2.0 (Non-
linear Dynamics) to allow for more accurate spot identifi-
cation [14]. Each gel was run in triplicate in parallel with
three independent sample preparations. The spot match-
ing across all gels without omitting values was set as a
requirement for spot merging for data analysis. An aver-
age gel with best resolution was generated using the three
independent replicates by including only those protein
spots that were present in at least two of the replicates.
The common spots, in keeping with shape and intensity
over all replicates, were selected for normalization of spot
volumes to equalize the probable variation in staining
trait. The gel containing all spots on final average gel was
used and transferred to the PVDF membrane which sub-
sequently was subjected to react with antisera from cattle.
In addition, image alignment and spot matching analyses
were performed on the gel spots and the immunogenic
protein spots detected by immunoblotting. The selected
spots were manually excised from the gels, and the gel
plugs containing the proteins were enzymatically digested
with porcine trypsin (modified sequencing grade; Pro-
mega, USA) as described previously [13]. The spots were
incubated with 50 mM ammonium bicarbonate (NH4CO3,
pH 7.8)/50% acetonitrile (ACN) for 1 h at 22 °C to de-
stain them and were washed and then dehydrated in
ACN. The dehydrated spots were vacuum-dried to remove
the solvent and then rehydrated overnight at 37 °C bydigestion with trypsin (10 ng/μL) in 50 mM NH4CO3
(pH 7.8). The tryptic peptides were extracted with 0.1%
trifluoroacetic acid (TFA)/50% can, and the combined
extracts were vacuum-dried by centrifugation and resus-
pended in 0.5% TFA. The peptide mixture was desalted
using ZipTip plates (Millipore) and then eluted with 0.2%
TFA/50% ACN. Finally, the resulting solution was mixed
with the matrix (10 mg/mL α-cyano-4-hydroxycinnamic
acid in 50% ACN/1% TFA).
Protein identification by MALDI-TOF MS /MS analysis
All spectra were collected using an ABI 4700 proteomics
analyzer Plus TOF-TOF Mass Spectrometer (Applied
Biosystems, USA). MS/MS data were obtained using this
instrument with a Nd:YAG laser with a 200 Hz repeti-
tion rate, and accumulation of up to 4000 shots were
performed for each spectrum from which the three high-
est intense peaks were processed to an enhanced reso-
lution. When the three intense peaks were subjected to
downstream analysis, these were ignored for a period of
60 s. MS/MS mode was operated with 2 keV collision
energy supplying air as the collision gas, which resulted
in completion of nominally single collision conditions.
MS/MS data were obtained using the default instrument
calibration without internal or external calibration. The
quality control parameters included based on the Mascot
algorithm were the following: maximum of one missed
cleavage permitted by trypsin, fixed modification (inclu-
ding residue specificity) of carbamidomethyl, variable
modifications (including residue specificity) of oxidation,
charge state of 12 to 14, mass tolerance for peptide ion
(m/z) of 0.1 to 0.2 Da, cut-off score/expectation value
for accepting individual MS spectra of highest expect-
ation (probability on profound search, PPS). All protein
identifications were made by only single protein spot
and were collected using a score with the minimal number
of high quality peptides per protein is 22. Peptide mass
data were used to query the NCBI protein sequence and
annotated genome databases of Brucella using the Mascot
search engine (Matrix Science, London, UK) [15]. Based
on the sequences identified using mass spectrometry, bio-
logical information on the chosen proteins was retrieved
using the EXPASY database [16]. The sub-cellular locali-
zations of bacterial proteins were predicted using PSORTb
v. 2.0.4 [17]. Functional annotations were made based on
the cluster of orthologous groups (COG) protein database
generated by comparing all of the complete sequences of
microbial genomes from the NCBI COG [18].
Results
2DE profiles of whole-cell antigens from B. abortus 544
The annotated 2DE proteome map of whole-cell proteins
from B. abortus 544 is shown in Figure 1A. A total of
1181 protein spots were detected on the silver-stained
Figure 1 2DE profile of B. abortus proteins and immunoblotting with antisera from B. abortus-infected cattle. (A) 2DE profile of proteins
from B. abortus detected on silver-stained 2DE gels within the pI range 4–7. Immunoblotting analyses were performed with antisera from cattle
after 3 (B), 7 (C), and 10 weeks (D) of challenge with B. abortus. Three replicates of 2DE analysis were performed in the independent experiments.
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of 4–7 and 20–240 kDa, respectively. The 2DE map pro-
files of the best resolution were obtained from most of the
detected spots in the 2DE gels of the three replicates from
separate experiments. These replicates were selected
based on equal 2D patterns and spot numbers reactive to
individual serum from three different infection periods.
The mean pI and Mr of all protein spots detected were
5.62 and 40.52 kDa, respectively. Using the broad pHrange from 3–10, the protein spots with pI < 4 or pI > 8
were detected at relatively low resolution with few protein
spots.
Immunogenic proteins in B. abortus at different infection
periods and comparison with cross-reacting bacteria
By immunoblotting the diverse B. abortus proteins
detected on 2DE gels, 134, 110, and 106 proteins were rec-
ognized using positive antisera from B. abortus-infected
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(Figures 1B-D). The negative sera from the non-infected
cattle and the positive antisera from the cattle infected
with Y. enterocolitica O:9 were also used for immunoblot-
ting to exclude non-specific or cross reactions. Few reac-
tions (25 protein spots) were observed using the negative
control (NC) and Y. enterocolitica O:9-positive (YP) anti-
sera (Table 1 and Figure 2). The spots reacting to the B.
abortus-positive (BP) antisera that overlapped with those
reacting to the NC (13 spots) and YP (13 spots) antisera
were excluded (Figure 3). Among the immunogenic pro-
teins that were not from non-specific and cross-reacting
spots, 120 immunodominant proteins (Table 1) were ob-
served using the antisera collected during at least one of
the three infection periods, whereas 101, 84, and 78 pro-
teins were specifically observed using BP antisera collected
at weeks 3, 7, and 10, respectively (Table 2 and Figure 4).
Fifty-five common antigens were predominantly specific
to the BP antisera at all three stages of infection (Figure 5A).
The percent similarity, calculated as the number of pro-
teins that reacted to the antisera, was 45.83%, suggesting
that highly immunogenic proteins were present in the
bovine serum within 10 weeks of infection (Table 1). In
addition, 19, 10, and 4 common immunoreactive spots
were observed at 3 and 7 (Figure 5B), 3 and 10 (Figure 5C),
and 7 and 10 weeks (Figure 5D), respectively. Furthermore,
17, 6, and 9 non-matched immunoreactive protein spots
were observed, and the percent independence of these
immunoreactions were 16.84%, 7.14%, and 11.54% at 3, 7,
and 10 weeks, respectively (Table 2).
Identification of immunogenic proteins at different
infection stages
Amongst the 55 immunogenic proteins detected at
all three stages of infection, the signal intensities of
23 immunogens were higher than the average whenTable 1 Comparison of immunoreactive proteins of B. abortus
Antisera immunoreactions compared No. of match
BP NC YP
Week 3 Week 7 Week 10
+b + + + + 8
+ + + + - 5
+ + + - + 5
+ + + - - 55
+ + - - - 19
+ - + - - 10
-c + + - - 4
NC - negative control, YP - Y. enterocolitica-positive sera, BP - B. abortus-positive ser
aThe percent similarity was calculated as the number of proteins common to the co
these antisera immunoreactions × 100.
bPositive reaction detected in immunoblotting.
cNegative reaction detected in immunoblotting.normalized to the total valid spot intensity; these 23
proteins were analyzed using MALDI- MS/MS. The
data revealed that several novel immunogenic proteins
with diverse ORF had varying values for Mr and pI in
MALDI-MS/MS (Table 3). NCBI BLAST searches of the
proteins identified using MALDI-MS/MS show that 10
(43.5%), 2 (8.7%) and 2 (8.7%) proteins were predicted
to have cytoplasmic, outer membrane-bound periplasmic
and ribosomal localization, respectively. However, 9 spots
(39.1%) were unknown proteins. Analysis of each identi-
fied protein indicates that 13 of the 23 proteins participate
in multiple enzymatic activities. Notably, three hypothet-
ical proteins (spots 187, 218 and 257) encoded by different
ORF had putative molecular functions such as catalytic
and protein disulfide oxidoreductase activities. The experi-
mental pI and Mr values from MALDI-MS/MS identifica-
tion were consistent with the theoretical values for most
identified proteins, with the exception of spot 146, which
was identified as an ABC transporter substrate-binding
protein; the experimental and theoretical Mr values for
this spot had the highest deviations (6.4).
Multiple proteins that were immunoreactive at all
stages of infection had varying pI, Mr and functions. The
identified proteins were sorted into functional groups
based on the classification of proteins encoded in com-
plete genomes established by COG: 14 were related to
transport and metabolism [4 for amino acids (spots 146,
178, 204, and 207), 3 to carbohydrates (spots 118, 164,
and 231), 2 to inorganic ions (spots 239 and 240), 2 to
nucleotides (spots 151 and 254), 2 to coenzymes (spots
161 and 169), and 1 to secondary metabolites (spot 218)];
3 were involved in ribosomal structure and biogenesis
related to protein translation (spots 162, 203, and 231),
and 2 were associated with cellular processes and signal-
ing, including post-translational modification, protein
turnover, and chaperones (spots 228 and 253).after immune challenge in cattle









mpared antisera immunoreactions divided by the total number of proteins in
Figure 2 2DE analysis and the immunoblotting profile detected using sera from non-infected and Y. enterocolitica-infected cattle. A
total of 25 immunoreactive dots were observed using the non-infected (A) and Y. enterocolitica-challenged (C) bovine sera, and the corresponding
proteins are labeled on the 2DE gel [NC (B) and YP (D)]. The numbers represent the serial numbers of the immunoreactive proteins in
immunoblotting analyses.
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Brucellosis is a re-emerging zoonosis that has regained
scientific attention because its pathogenesis in human
and animal disease has significantly evolved [1,19]. How-
ever, the overall burden of this disease remains underes-
timated and is not well studied. The disease ecology has
evolved rapidly in recent years, and there are novel pop-
ulations with high risk of exposure and the potential to
develop chronic or latent infection [20]. Eradication ofbrucellosis in animals is important for prevention of this
disease in human beings and requires optimal diagnosis
and vaccination [3]. There are relatively efficient diag-
nostic tests for brucellosis, and vaccines have been con-
sistently developed; however, there are still several
limitations [21,22]. Furthermore, cross-reacting bacteria
decrease the specificity of the tests, and this has im-
peded the control of brucellosis [7]. To address these
problems, it is important to develop new strategies for
Figure 3 Comparative 2DE analysis of B. abortus proteins and immunoblotting profile of non-specific reactions. A total of 13
immunoreactive spots of common antigens that responded to the negative sera from non-infected cattle (A) and positive sera of Y. enterocolitica
(B), and three types of sera from cattle after 3, 7 and 10 weeks of challenge with B. abortus were selected. The numbers represent the serial numbers
of the immunoreactive proteins in immunoblot analyses.
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focused on identifying immunogenic proteins of Brucella
from three different stages of infection (short-, middle-,
and long-term) for the improvement of immunodiagnos-
tics. Although distinct sets of Brucella antigens were only
a limited set of proteins present at all three time points,
these novel immunodominant proteins identified in our
study might be suitable for the detection of B. abortus
infection.
The 2DE gels containing B. abortus whole cell proteins
were subjected to immunoblotting analysis using bovine
antisera; the antisera were collected at three different
phases of infection: the early (week 3), middle (week 7),
and late (week 10) periods after challenge with B. abortus.
An important diagnostic problem is the similarity of the
O-antigenic side chains of Brucella and other Gram-
negative bacteria such as Y. enterocolitica O:9 [7]. In





Periods of challenge week 3 17
week 7 6
week 10 9
BP - B. abortus-positive sera.
aThe percent independence was calculated as the number of non-matched protein
number of proteins in these antisera immunoreactions × 100.O:9-positive (YP) antisera and negative control (NC) sera
in cattle were detected. By immunoblotting-linked gel
image analysis of B. abortus proteins, the overlapping
spots that were reactive to the YP and NC sera were
excluded, and the spots that were reactive to the B. abor-
tus-positive (BP) antisera at all stages of infection were
selected; this analysis identified 120 distinct spots. The
total number of spots reactive to the BP antisera at 3, 7,
and 10 weeks post-challenge was comparable to the num-
ber of common spots (55) observed at all stages of infec-
tion. Furthermore, the common spots were 45.83% similar
to those observed by immunoblotting using antisera from
all three stages of infection; this suggests that the common
immunoreactive spots might represent the proteins that
are immunodominant at all stages of infection. The in-
fection time-independent immunodominant proteins of
B. abortus comprise proteins expressed from diverse









s to the antisera immunoreactions compared with others divided by the total
Figure 4 Immunoblotting profile of B. abortus proteins responded with B. abortus-infected bovine antisera excluding non-specific proteins.
Immunoblotting analyses were performed with antisera from cattle after 3, 7, and 10 weeks of challenge with B. abortus. After excluding non-specific
reactions, a total of 101 (A), 84 (B), and 78 (C) immunoreactive dots, as well as 55 protein spots that reacted with antisera at all 3 stages (D, E, and F),
were selected and labeled. The numbers represent the serial numbers of the immunoreactive proteins in immunoblot analyses.
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the immunogenicity of Brucella antigens but did not cor-
relate this immunogenicity with the stage of infection.
Therefore, this study identified several novel immunore-
active proteins in the bovine host based on the stage of
infection.
Using the COG approach, most of the identified pro-
teins were assigned functions related to the transport
and metabolism of amino acids (60.9%). The 27.6 kDa
DHDPR protein encoded by the dapB gene had the
highest score value; DHDPR was proposed to function
in the biosynthesis of lysine and diaminopimelate, but
few proteomic studies have examined the role of this pro-
tein in Brucella infection [23]. The dapB in Burkholderia
pseudomallei is an essential gene that was successfully
mutagenized and identified as a beneficial marker [24].
Therefore, because the B. abortus dapB-encoded protein
elicits an immunodominant response, this protein is a
relevant candidate marker for infection. The predicted
proteins involved in carbohydrate transport and metabol-
ism included malate dehydrogenase (mdh), which functionsin malate metabolism and the tricarboxylic acid cycle.
mdh is expressed in response to acidic stress [25] and
was broadly identified in B. abortus [10] and B. melitensis
[26] using proteomic analyses. The second most frequent
group included proteins related to ribosomal structure
and protein translation. This group includes two riboso-
mal proteins, the 30S ribosomal protein S2 (RPS2) and the
50S ribosomal protein L25 (RPL25), and one translation
elongation factor, EF-Ts (tsf). The RPS2 protein is highly
conserved in prokaryotic-type ribosomes and is essential
for binding of the ribosomal protein S1 to the 30S riboso-
mal subunit in E. coli [27]. In Brucella, RPS2 is repressed
in response to oxidative stress [25] and is generally identi-
fied as the SSU ribosomal protein S1P of B. melitensis and
B. abortus [10,26]. Additionally, elongation factor Ts (tsf),
which is associated with protein translation, might be crit-
ical for the immunogenicity of B. abortus; this observation
is consistent with previous data obtained by global protein
analysis in B. melitensis [26]. Our study is the first to
report that this protein is immunogenic at all stages
of infection.
Figure 5 Comparative 2DE analysis of B. abortus proteins and immunoblotting profiles of specific reactions. (A) A total of 55
immunoreactive spots of antigen that responded to antisera from cattle after 3, 7 and 10 weeks of challenge with B. abortus were selected. A
total of 19, 10, and 4 immunoreactive spots of antigen responded to antisera at 2 time-points: (B) after 3 and 7 weeks of challenge, (C) after 3
and 10 weeks, and (D) after 7 and 10 weeks; these spots were selected and labeled on the 2DE gel. The numbers represent the serial numbers of
the immunoreactive proteins in immunoblot analyses.
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transport and metabolism, the 22.5 kDa Fe-Mn super-
oxide dismutase (Fe-Mn-SOD) detected at the pI of 5.58
is an oxidoreductase with superoxide dismutase activity.
The Fe-Mn-SOD protein of B. melitensis is correlated
with regulation of the stress response and was identified
as a heat-shock protein (Hsp) [25]. Furthermore, the roleof metal ions such as Fe and Mn in the response to
relatively stringent environments has been elucidated
with respect to Brucella pathogenesis [28]. Similar to
the regulation of Fe- and/or Mn-SOD in response to
heat shock and oxidative stress in some bacteria [29], B.
abortus Fe-Mn-SOD is an essential factor that regulates
specific stress responses inside hosts. Several molecular

















118 BruAb2_0325 3341905 aldehyde
dehydrogenase
YP_223118.1 Q579C7 500 BruAb2_0325 249 53744 53435 5.64 29 unknown G: Carbohydrate
transport and
metabolism









151 aspC 3339882 aspartate
aminotransferase
YP_222177.1 Q57C18 400 BruAb1_1488 193 43812 43554 5.94 18 unknown F: Nucleotide
transport and
metabolism
161 BruAb1_0775 3339474 3-hydroxyisobutyryl-
CoA hydrolase
YP_221504.1 Q57DZ1 349 BruAb1_0775 258 38120 37802 4.84 27 unknown H: Coenzyme
transport and
metabolism




164 mdh 3340925 malate dehydrogenase YP_222574.1 Q57AX1 320 BruAb1_1903 76 33854 33704 5.24 7 cytoplasm G: Carbohydrate
transport and
metabolism
169 tbpA 3340057 thiamine transporter
substrate binding
subunit





178 BruAb1_1058 3341091 cysteine synthase A YP_221767.1 Q57D78 342 BruAb1_1058 417 34445 36701 5.94 30 cytoplasm E: Amino acid
transport and
metabolism
187 BruAb2_0291 3341871 hypothetical protein
BruAb2_0291
YP_223086.1 Q579F9 330 BruAb2_0291 267 35457 35251 5.50 26 unknown R: General
function
prediction only
203 rpsB 3340672 30S ribosomal
protein S2




204 ubiG 3340925 3-demethylubiquinone-
9 3-methyltransferase
YP_415219.1 Q2YLN5 248 BAB1_1875 410 27653 27486 5.79 31 cytoplasm E: Amino acid
transport and
metabolism
207 dapB 3341712 dihydrodipicolinate
reductase












Table 3 Identification of matched immunoreactive proteins of B. abortus that reacted with B. abortus-positive bovine antisera (Continued)
218 BruAb2_0647 3342272 hypothetical protein
BruAb2_0647





227 BruAb2_0628 3342294 metal-dependent
hydrolase
YP_223400.1 Q577Z5 237 BruAb2_0628 511 25223 25124 5.58 51 cytoplasm R: General
function
prediction only
228 msrA 3341844 methionine sulfoxide
reductase A





231 BruAb1_1470 3340810 50S ribosomal
protein L25




239 BruAb1_0588 3339410 Fe-Mn superoxide
dismutase
YP_221327.1 Q57EG8 199 BruAb1_0588 359 22526 22540 5.83 37 unknown P: Inorganic ion
transport and
metabolism
240 rocF 3341875 arginase YP_223125.1 P0A2Y1 306 BruAb2_0333 188 33415 33182 5.63 24 unknown P: Inorganic ion
transport and
metabolism
243 gpm 3341713 phosphoglyceromutase YP_223732.1 Q576R3 206 BruAb2_0992 446 22929 22886 6.16 43 cytoplasm G: Carbohydrate
transport and
metabolism
253 secB 3339678 preprotein translocase
subunit SecB





254 ndk 3339959 nucleoside
diphosphate kinase
YP_221449.1 Q57E46 140 BruAb1_0713 58 15269 15278 5.27 20 cytoplasm F: Nucleotide
transport and
metabolism
257 BruAb2_0845 3341366 hypothetical protein
BruAb2_0845
YP_223598.1 Q577E7 177 BruAb2_0845 500 18506 18517 5.02 43 unknown S: Function
unknown
263 ohr 3341640 organic hydroperoxide
resistance protein
YP_223139.1 Q579A6 140 BruAb2_0347 8 14337 14232 5.63 13 unknown R: General
function
prediction only
aGene ID, protein ID, accession no. and locus tag were retrieved from the NCBInr database.
bTheoretical molecular weight from the UniProtKB database entry.
cSubcellular locations were predicted using PSORTb v. 2.0.4.
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ase, are known as stress proteins and virulence factors
[25,30,31]; in our study, at least one chaperone protein,
the pre-protein translocase subunit (SecB) was specific to
a certain B. abortus-infection stage. SecB is a molecular
chaperone specific to the proteobacteria, which comprises
most gram-negative bacteria that are medically and indus-
trially relevant [32]. SecB is required for the normal export
of pre-proteins out of the cytoplasm, keeping them in a
translocation-competent state.
Prevention of Brucella infections in livestock generally
involves the use of live attenuated vaccines such as B.
abortus (RB51 or S19) [33,34] and B. melitensis Rev1 [35].
S19 and Rev1 had the major disadvantage of inducing
O-side chain-specific antibodies, which causes cross-
reactivity during diagnosis; with RB51, the recovery of
virulence was a major problem [36]. Consistently, sev-
eral studies have focused on developing next-generation
vaccines that are more safe and effective. Therefore, the
immunogenic Brucella proteins identified in this study
might provide supporting information for developing
valid vaccine candidates that can elicit an efficient and
specific immune response. Furthermore, it is important
to consider the diagnostic method used depending on
the animal and the stage of infection. Modern diagnostic
methods are based on molecular approaches developed
by proteomic analyses, and these advanced tools might
soon replace the older, limited diagnostic methods. We
suggest that the candidate proteins elucidated in this
study might contribute a valuable solution to the pre-
sent problems in the diagnosis of brucellosis, independent
of the stage of infection. Ultimately, our investigation
could provide helpful insight to advance the potential of
immunogenic proteins as determinants for serological
diagnosis and as novel tools for prevention of Brucella
infection.
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